Cogent Biosciences Inc (COGT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.97B
Last updated: Nov 17, 2026 at 11:05 AM ET
Cogent Biosciences Inc (COGT) Earnings: Report Dates and Results
Cogent Biosciences (COGT) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Cogent Biosciences reported EPS of -$0.59, below the -$0.57 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
COGT has an expected report date of Feb 15, 2027.
Earnings History
Of the 34 quarters below that had an estimate, COGT beat 12 and missed 22. The widest gap in the table came in the quarter ended Sep 30, 2020, when EPS landed 628.57% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.59 | -$0.57 | -$0.64 - -$0.45 | -3.51% | Miss | N/A | 8 | 0 up, 1 down | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$0.52 | -$0.55 | -$0.66 - -$0.49 | +5.45% | Beat | N/A | 10 | 2 up, 4 down | Aug 10, 2026 | N/A |
| Mar 31, 2026 | -$0.53 | -$0.50 | -$0.66 - -$0.46 | -5.66% | Miss | N/A | 8 | 1 up, 3 down | May 5, 2026 | N/A |
| Dec 31, 2025 | -$0.56 | -$0.51 | -$0.60 - -$0.41 | -9.80% | Miss | N/A | 12 | 1 up, 0 down | Feb 17, 2026 | N/A |
| Sep 30, 2025 | -$0.50 | -$0.52 | -$0.59 - -$0.42 | +3.85% | Beat | N/A | 12 | 5 up, 3 down | Nov 7, 2025 | N/A |
| Jun 30, 2025 | -$0.53 | -$0.58 | -$0.66 - -$0.38 | +8.62% | Beat | N/A | 11 | 1 up, 2 down | Aug 5, 2025 | N/A |
| Mar 31, 2025 | -$0.52 | -$0.58 | -$0.65 - -$0.44 | +9.05% | Beat | N/A | 7 | 1 up, 0 down | May 6, 2025 | N/A |
| Dec 31, 2024 | -$0.09 | -$0.58 | -$0.67 - -$0.45 | +84.48% | Beat | N/A | 9 | 4 up, 5 down | Feb 25, 2025 | $4.29M |
| Sep 30, 2024 | -$0.64 | -$0.57 | -$0.67 - -$0.44 | -12.28% | Miss | N/A | 11 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$0.59 | -$0.55 | -$0.66 - -$0.33 | -7.27% | Miss | N/A | 10 | 0 up, 0 down | Aug 6, 2024 | N/A |
| Mar 31, 2024 | -$0.62 | -$0.51 | -$0.59 - -$0.40 | -21.57% | Miss | N/A | 9 | 0 up, 0 down | May 7, 2024 | N/A |
| Dec 31, 2023 | -$0.63 | -$0.56 | -$0.66 - -$0.37 | -12.50% | Miss | N/A | 11 | 0 up, 0 down | Feb 26, 2024 | $5.59M |
| Sep 30, 2023 | -$0.64 | -$0.53 | -$0.60 - -$0.41 | -20.75% | Miss | N/A | 9 | 0 up, 0 down | Nov 2, 2023 | N/A |
| Jun 30, 2023 | -$0.59 | -$0.46 | -$0.64 - -$0.45 | -28.26% | Miss | N/A | 9 | 1 up, 0 down | Aug 8, 2023 | N/A |
| Mar 31, 2023 | -$0.57 | -$0.53 | -$0.67 - -$0.45 | -7.55% | Miss | N/A | 8 | 0 up, 0 down | May 9, 2023 | N/A |
| Dec 31, 2022 | -$0.56 | -$0.52 | -$0.58 - -$0.40 | -7.69% | Miss | N/A | 7 | 0 up, 0 down | Mar 14, 2023 | N/A |
| Sep 30, 2022 | -$0.50 | -$0.52 | -$0.58 - -$0.39 | +3.85% | Beat | N/A | 6 | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$0.71 | -$0.68 | N/A | -4.41% | Miss | N/A | N/A | 1 up, 0 down | Aug 9, 2022 | N/A |
| Mar 31, 2022 | -$0.68 | -$0.49 | -$0.63 - -$0.33 | -38.78% | Miss | N/A | 6 | 0 up, 0 down | May 10, 2022 | N/A |
| Dec 31, 2021 | -$0.60 | -$0.46 | -$0.58 - -$0.31 | -30.43% | Miss | N/A | 7 | N/A | Mar 15, 2022 | N/A |
| Sep 30, 2021 | -$0.48 | -$0.38 | -$0.53 - -$0.27 | -26.32% | Miss | N/A | 6 | 2 up, 0 down | Nov 10, 2021 | N/A |
| Jun 30, 2021 | -$0.43 | -$0.35 | -$0.57 - -$0.18 | -22.86% | Miss | N/A | 6 | N/A | Aug 16, 2021 | N/A |
| Mar 31, 2021 | -$0.34 | -$0.22 | -$0.68 - -$0.17 | -54.55% | Miss | N/A | 6 | N/A | May 12, 2021 | N/A |
| Dec 31, 2020 | -$6.06 | -$0.51 | -$1.79 - -$0.15 | N/A | N/A | -2264.3% | 6 | N/A | Mar 16, 2021 | N/A |
| Sep 30, 2020 | -$1.02 | -$0.14 | N/A | -628.57% | Miss | N/A | N/A | N/A | Nov 9, 2020 | $312000 |
| Jun 30, 2020 | -$0.96 | -$0.84 | N/A | -14.29% | Miss | N/A | N/A | N/A | Aug 11, 2020 | $528000 |
| Mar 31, 2020 | -$0.80 | -$1.23 | N/A | +34.96% | Beat | N/A | N/A | N/A | May 11, 2020 | $7.03M |
| Dec 31, 2019 | $0.28 | -$1.14 | N/A | +124.56% | Beat | N/A | N/A | N/A | Mar 26, 2020 | $15.29M |
| Sep 30, 2019 | -$1.56 | -$1.30 | N/A | -20.00% | Miss | N/A | N/A | N/A | Nov 12, 2019 | $1.02M |
| Jun 30, 2019 | -$1.36 | -$1.60 | N/A | +15.00% | Beat | N/A | N/A | N/A | Aug 12, 2019 | $3.14M |
| Mar 31, 2019 | -$1.56 | -$1.33 | N/A | -17.29% | Miss | N/A | N/A | N/A | May 13, 2019 | $3.05M |
| Dec 31, 2018 | -$1.16 | -$1.41 | N/A | +17.73% | Beat | N/A | N/A | N/A | Mar 28, 2019 | $3.81M |
| Sep 30, 2018 | -$1.36 | -$1.40 | N/A | +2.86% | Beat | N/A | N/A | N/A | Nov 12, 2018 | $2.04M |
| Jun 30, 2018 | -$1.24 | -$1.38 | N/A | +10.14% | Beat | N/A | N/A | N/A | Aug 13, 2018 | $1.67M |
| Mar 31, 2018 | -$0.66 | -$0.36 | N/A | -83.33% | Miss | N/A | N/A | N/A | May 14, 2018 | $2.22M |
| Dec 31, 2017 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2018 | $2.12M |
| Sep 30, 2017 | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 3, 2017 | $2.33M |
| Mar 31, 2017 | -$0.58 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2017 | $1.83M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.11, after -$1.94 the year before. It was -$1.22 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.11 | N/A |
| Dec 31, 2024 | -$1.94 | N/A |
| Dec 31, 2023 | -$2.43 | N/A |
| Dec 31, 2022 | -$2.45 | N/A |
| Dec 31, 2021 | -$1.85 | N/A |
| Dec 31, 2020 | -$8.84 | N/A |
| Dec 31, 2019 | -$4.20 | N/A |
| Dec 31, 2018 | -$4.42 | N/A |
| Dec 31, 2017 | -$1.22 | N/A |
Frequently Asked Questions About COGT
When is Cogent Biosciences's next earnings date?
Cogent Biosciences's next earnings report is expected for Feb 15, 2027.
Did COGT beat earnings estimates last quarter?
No. Cogent Biosciences reported EPS of -$0.59 for the quarter ended Sep 30, 2026, below the -$0.57 estimate by 3.51%.
What EPS do analysts expect from COGT next quarter?
The consensus EPS estimate for Cogent Biosciences for the quarter ending Dec 31, 2026 is -$0.64 from 13 analysts, with estimates from -$0.72 to -$0.55.
How often does COGT beat earnings estimates?
Cogent Biosciences beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +11.56%.
COGT pages: Overview, Earnings, Forecast, Financials, Competitors